In "The Lancet Series on Antimicrobial Resistance: The need for sustainable access to effective antibiotics," authored by experts convened by OHT's Dr. Ramanan Laxminarayan, the authors propose achievable targets of 10-20-30 by 2030 to tackle the #AMR issue. These targets align with the global effort to combat AMR, with the United Nations High-Level Meeting on AMR taking place in September 2024. Learn more about these targets in The Lancet series here: https://ow.ly/oLvH50SwHIn #UNGA2024 #Goals #EndAMR #GlobalHealth
One Health Trust’s Post
More Relevant Posts
-
Antimicrobial Resistance (#AMR) poses an imminent threat to both humans and the environment. This year's World AMR Awareness Week theme, "Preventing Antimicrobial Resistance Together", highlights the essential need for cross-sectoral collaboration to combat this issue effectively. In the battle against AMR, every sector must use antimicrobials judiciously and implement preventive measures to reduce infections. Precision in diagnostics plays a pivotal role in restraining unnecessary antibiotic use, a critical step in preserving the efficacy of antimicrobials. #WAAW2023 serves as a unifying platform, bringing together healthcare professionals, policymakers, researchers, and the public to raise awareness and address AMR collectively, shaping a healthier future for all.
-
AHRQ is funding innovative #research proposals to prevent healthcare-associated infections (HAIs) and combat antibiotic-resistant bacteria (CARB). Applications are due May 25 for demonstration and dissemination projects (R18) and June 5 for large research projects (R01). HAI projects in both grant categories should demonstrate new ways to detect, prevent and reduce HAIs. CARB projects should address ways to promote appropriate antibiotic use, reduce the transmission of resistant bacteria, or prevent HAIs. AHRQ encourages potential applicants to consider research in healthcare delivery areas with demonstrated health inequities and to address those equity issues in their proposed projects. https://bit.ly/3hCuF3d
-
-
AHRQ is funding innovative #research proposals to prevent healthcare-associated infections (HAIs) and combat antibiotic-resistant bacteria (CARB). Applications are due May 25 for demonstration and dissemination projects (R18) and June 5 for large research projects (R01). HAI projects in both grant categories should demonstrate new ways to detect, prevent and reduce HAIs. CARB projects should address ways to promote appropriate antibiotic use, reduce the transmission of resistant bacteria, or prevent HAIs. AHRQ encourages potential applicants to consider research in healthcare delivery areas with demonstrated health inequities and to address those equity issues in their proposed projects. https://bit.ly/3hCuF3d
-
-
AHRQ is funding innovative #research proposals to prevent healthcare-associated infections (HAIs) and combat antibiotic-resistant bacteria (CARB). Applications are due May 25 for demonstration and dissemination projects (R18) and June 5 for large research projects (R01). HAI projects in both grant categories should demonstrate new ways to detect, prevent and reduce HAIs. CARB projects should address ways to promote appropriate antibiotic use, reduce the transmission of resistant bacteria, or prevent HAIs. AHRQ encourages potential applicants to consider research in healthcare delivery areas with demonstrated health inequities and to address those equity issues in their proposed projects. https://bit.ly/3hCuF3d
-
-
Official Page of the Director, Center for Quality Improvement and Patient Safety at Agency for Healthcare Research and Quality
AHRQ is funding innovative #research proposals to prevent healthcare-associated infections (HAIs) and combat antibiotic-resistant bacteria (CARB). Applications are due May 25 for demonstration and dissemination projects (R18) and June 5 for large research projects (R01). HAI projects in both grant categories should demonstrate new ways to detect, prevent and reduce HAIs. CARB projects should address ways to promote appropriate antibiotic use, reduce the transmission of resistant bacteria, or prevent HAIs. AHRQ encourages potential applicants to consider research in healthcare delivery areas with demonstrated health inequities and to address those equity issues in their proposed projects. https://bit.ly/3hCuF3d
-
-
AHRQ is funding innovative #research proposals to prevent healthcare-associated infections (HAIs) and combat antibiotic-resistant bacteria (CARB). Applications are due May 25 for demonstration and dissemination projects (R18) and June 5 for large research projects (R01). HAI projects in both grant categories should demonstrate new ways to detect, prevent and reduce HAIs. CARB projects should address ways to promote appropriate antibiotic use, reduce the transmission of resistant bacteria, or prevent HAIs. AHRQ encourages potential applicants to consider research in healthcare delivery areas with demonstrated health inequities and to address those equity issues in their proposed projects. https://bit.ly/3hCuF3d
-
-
Official Page of the Director, Center for Quality Improvement and Patient Safety at Agency for Healthcare Research and Quality
AHRQ is funding innovative #research proposals to prevent healthcare-associated infections (HAIs) and combat antibiotic-resistant bacteria (CARB). Applications are due May 25 for demonstration and dissemination projects (R18) and June 5 for large research projects (R01). HAI projects in both grant categories should demonstrate new ways to detect, prevent and reduce HAIs. CARB projects should address ways to promote appropriate antibiotic use, reduce the transmission of resistant bacteria, or prevent HAIs. AHRQ encourages potential applicants to consider research in healthcare delivery areas with demonstrated health inequities and to address those equity issues in their proposed projects. https://bit.ly/3hCuF3d
-
-
Official Page of the Director, Center for Quality Improvement and Patient Safety at Agency for Healthcare Research and Quality
AHRQ is funding innovative #research proposals to prevent healthcare-associated infections (HAIs) and combat antibiotic-resistant bacteria (CARB). Applications are due May 25 for demonstration and dissemination projects (R18) and June 5 for large research projects (R01). HAI projects in both grant categories should demonstrate new ways to detect, prevent and reduce HAIs. CARB projects should address ways to promote appropriate antibiotic use, reduce the transmission of resistant bacteria, or prevent HAIs. AHRQ encourages potential applicants to consider research in healthcare delivery areas with demonstrated health inequities and to address those equity issues in their proposed projects. https://bit.ly/3hCuF3d
-
-
AHRQ is funding innovative #research proposals to prevent healthcare-associated infections (HAIs) and combat antibiotic-resistant bacteria (CARB). Applications are due May 25 for demonstration and dissemination projects (R18) and June 5 for large research projects (R01). HAI projects in both grant categories should demonstrate new ways to detect, prevent and reduce HAIs. CARB projects should address ways to promote appropriate antibiotic use, reduce the transmission of resistant bacteria, or prevent HAIs. AHRQ encourages potential applicants to consider research in healthcare delivery areas with demonstrated health inequities and to address those equity issues in their proposed projects. https://bit.ly/3hCuF3d
-
-
Official Page of the Director, Center for Quality Improvement and Patient Safety at Agency for Healthcare Research and Quality
AHRQ is funding innovative #research proposals to prevent healthcare-associated infections (HAIs) and combat antibiotic-resistant bacteria (CARB). Applications are due May 25 for demonstration and dissemination projects (R18) and June 5 for large research projects (R01). HAI projects in both grant categories should demonstrate new ways to detect, prevent and reduce HAIs. CARB projects should address ways to promote appropriate antibiotic use, reduce the transmission of resistant bacteria, or prevent HAIs. AHRQ encourages potential applicants to consider research in healthcare delivery areas with demonstrated health inequities and to address those equity issues in their proposed projects. https://bit.ly/3hCuF3d
-
Scientist, Indian Council of Medical Rresearch I Drug Discovery I Pharmacologist I
1wVery informative. AMR and 10-20-30 by 2030 would be a landmark if all stakeholders join hands together.